Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-25,000
Closed -$2.42M 50
2022
Q3
$2.42M Buy
25,000
+1,600
+7% +$171K 0.08% 305
2022
Q2
$2.54M Buy
23,400
+5,100
+28% +$579K 0.09% 278
2022
Q1
$2.17M Buy
18,300
+7,800
+74% +$967K 0.07% 303
2021
Q4
$1.48M Sell
10,500
-3,100
-23% -$397K 0.05% 442
2021
Q3
$1.61M Sell
13,600
-48,100
-78% -$5.91M 0.05% 556
2021
Q2
$7.15M Buy
61,700
+55,800
+946% +$6.5M 0.23% 65
2021
Q1
$707K Buy
+5,900
New +$699K 0.02% 760

Other funds holding ABT

Point72 Hong Kong's ABT Position: Q2 2024 in Review

Point72 Hong Kong sold out of Abbott (ABT) in Q2 2024, closing a stake of 233,900 shares — an estimated $26.6M sold.

Point72 Hong Kong first reported a position in ABT in Q3 2014 and held it in 16 quarters. The position peaked at $26.6M in Q1 2024. 2,862 funds tracked by Wall St. Rank hold ABT as of Q2 2024.

  • Point72 Hong Kong reported no remaining Abbott position as of Q2 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 233,900 Abbott shares in Q2 2024, an estimated $26.6M.
  • Point72 Hong Kong first reported a position in Abbott in Q3 2014 and held it in 16 quarters.
  • Point72 Hong Kong's Abbott position peaked at $26.6M in Q1 2024.
  • 2,862 funds tracked by Wall St. Rank held Abbott as of Q2 2024.

Based on Point72 Hong Kong's 13F filing for Q2 2024, filed 14 Aug 2024.